Aura Biosciences, Inc.
AURA
$6.55
$0.081.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.73M | 5.69M | 5.47M | 6.20M | 5.88M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.61M | 29.04M | 27.81M | 23.23M | 22.76M |
| Operating Income | -28.61M | -29.04M | -27.81M | -23.23M | -22.76M |
| Income Before Tax | -26.97M | -27.47M | -25.81M | -21.00M | -20.34M |
| Income Tax Expenses | 48.00K | 18.00K | 24.00K | 43.00K | -- |
| Earnings from Continuing Operations | -27.02M | -27.48M | -25.83M | -21.04M | -20.34M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -27.02M | -27.48M | -25.83M | -21.04M | -20.34M |
| EBIT | -28.61M | -29.04M | -27.81M | -23.23M | -22.76M |
| EBITDA | -28.33M | -28.74M | -27.52M | -22.92M | -22.45M |
| EPS Basic | -0.47 | -0.55 | -0.52 | -0.42 | -0.41 |
| Normalized Basic EPS | -0.29 | -0.34 | -0.32 | -0.26 | -0.26 |
| EPS Diluted | -0.47 | -0.55 | -0.52 | -0.42 | -0.41 |
| Normalized Diluted EPS | -0.29 | -0.34 | -0.32 | -0.26 | -0.26 |
| Average Basic Shares Outstanding | 58.02M | 50.13M | 49.94M | 49.66M | 49.55M |
| Average Diluted Shares Outstanding | 58.02M | 50.13M | 49.94M | 49.66M | 49.55M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |